186 related articles for article (PubMed ID: 38554117)
1. Tissue-resident memory T cells in immunotherapy and immune-related adverse events by immune checkpoint inhibitor.
Xiong H; Shen Z
Int J Cancer; 2024 Jul; 155(2):193-202. PubMed ID: 38554117
[TBL] [Abstract][Full Text] [Related]
2. Resident memory T cells, critical components in tumor immunology.
Mami-Chouaib F; Blanc C; Corgnac S; Hans S; Malenica I; Granier C; Tihy I; Tartour E
J Immunother Cancer; 2018 Sep; 6(1):87. PubMed ID: 30180905
[TBL] [Abstract][Full Text] [Related]
3. Tissue-resident memory CD8
Wang T; Shen Y; Luyten S; Yang Y; Jiang X
Pharmacol Res; 2020 Sep; 159():104876. PubMed ID: 32422340
[TBL] [Abstract][Full Text] [Related]
4. Interferon-Gamma-Producing CD8
Sasson SC; Slevin SM; Cheung VTF; Nassiri I; Olsson-Brown A; Fryer E; Ferreira RC; Trzupek D; Gupta T; Al-Hillawi L; Issaias ML; Easton A; Campo L; FitzPatrick MEB; Adams J; Chitnis M; Protheroe A; Tuthill M; Coupe N; Simmons A; Payne M; Middleton MR; Travis SPL; ; Fairfax BP; Klenerman P; Brain O
Gastroenterology; 2021 Oct; 161(4):1229-1244.e9. PubMed ID: 34147519
[TBL] [Abstract][Full Text] [Related]
5. Tissue-resident memory T cells in tumor immunity and immunotherapy.
Okła K; Farber DL; Zou W
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33755718
[TBL] [Abstract][Full Text] [Related]
6. The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin?
Reschke R; Deitert B; Enk AH; Hassel JC
Front Immunol; 2024; 15():1385781. PubMed ID: 38562921
[TBL] [Abstract][Full Text] [Related]
7. The Potential of Tissue-Resident Memory T Cells for Adoptive Immunotherapy against Cancer.
Beumer-Chuwonpad A; Taggenbrock RLRE; Ngo TA; van Gisbergen KPJM
Cells; 2021 Aug; 10(9):. PubMed ID: 34571883
[TBL] [Abstract][Full Text] [Related]
8. The Emerging Interplay Between Recirculating and Tissue-Resident Memory T Cells in Cancer Immunity: Lessons Learned From PD-1/PD-L1 Blockade Therapy and Remaining Gaps.
Gitto S; Natalini A; Antonangeli F; Di Rosa F
Front Immunol; 2021; 12():755304. PubMed ID: 34867987
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of tissue-resident memory T cells in infections and cancer.
Yenyuwadee S; Sanchez-Trincado Lopez JL; Shah R; Rosato PC; Boussiotis VA
Sci Adv; 2022 Aug; 8(33):eabo5871. PubMed ID: 35977028
[TBL] [Abstract][Full Text] [Related]
10. Significance of CD103
Natsuki S; Tanaka H; Nishiyama M; Deguchi S; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Maeda K
BMC Cancer; 2023 Oct; 23(1):1011. PubMed ID: 37864146
[TBL] [Abstract][Full Text] [Related]
11. Targeting Resident Memory T Cells for Cancer Immunotherapy.
Blanc C; Hans S; Tran T; Granier C; Saldman A; Anson M; Oudard S; Tartour E
Front Immunol; 2018; 9():1722. PubMed ID: 30100906
[TBL] [Abstract][Full Text] [Related]
12. [Advances in the Study of Tissue-resident Memory T Cells in Lung Cancer].
Tan S; Tian P
Zhongguo Fei Ai Za Zhi; 2022 Dec; 25(12):862-869. PubMed ID: 36617472
[TBL] [Abstract][Full Text] [Related]
13. Tissue-resident memory T cells in immune-related adverse events: friend or foe?
Reschke R; Gajewski TF
Oncoimmunology; 2023; 12(1):2197358. PubMed ID: 37035636
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
15. Tissue-resident memory-like T cells in tumor immunity: Clinical implications.
Dhodapkar MV; Dhodapkar KM
Semin Immunol; 2020 Jun; 49():101415. PubMed ID: 33011063
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells.
Burbach BJ; O'Flanagan SD; Shao Q; Young KM; Slaughter JR; Rollins MR; Street TJL; Granger VE; Beura LK; Azarin SM; Ramadhyani S; Forsyth BR; Bischof JC; Shimizu Y
Nat Commun; 2021 Jun; 12(1):3862. PubMed ID: 34162858
[TBL] [Abstract][Full Text] [Related]
17. Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy.
Damei I; Trickovic T; Mami-Chouaib F; Corgnac S
Front Immunol; 2023; 14():1205984. PubMed ID: 37545498
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitor-associated gastritis: Patterns and management.
Lin J; Lin ZQ; Zheng SC; Chen Y
World J Gastroenterol; 2024 Apr; 30(14):1941-1948. PubMed ID: 38681126
[TBL] [Abstract][Full Text] [Related]
19. Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?
Abdeljaoued S; Arfa S; Kroemer M; Ben Khelil M; Vienot A; Heyd B; Loyon R; Doussot A; Borg C
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35470231
[TBL] [Abstract][Full Text] [Related]
20. Immunopathological basis of immune-related adverse events induced by immune checkpoint blockade therapy.
Kubo T; Hirohashi Y; Tsukahara T; Kanaseki T; Murata K; Morita R; Torigoe T
Immunol Med; 2022 Jun; 45(2):108-118. PubMed ID: 34542015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
